Related content

Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome

By Koiou Ekaterini   Tziomalos Konstantinos   Katsikis Ilias   Papadakis Efstathios   Kandaraki Eleni A.   Panidis Dimitrios  

Gynecological Endocrinology, Vol. 29, Iss. 3, 2013-03 ,pp. : 250-253

Informa Healthcare

Access to resources Recommend Favorite

Obesity and insulin resistance in women with polycystic ovary syndrome

By Chun-Sen Hsu   Chien-Hua Wu   Wan-Chun Chiu   Ching-Tzu Lee   Chun-Jen Chang   Ming-I Hsu  

Gynecological Endocrinology, Vol. 27, Iss. 5, 2011-05 ,pp. : 300-306

Informa Healthcare

Access to resources Recommend Favorite

Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance

By Lemay A.   Dodin S.   Turcot L.   Déchêne F.   Forest J-C.  

Human Reproduction, Vol. 21, Iss. 1, 2006-01 ,pp. : 121-128

Oxford University Press

Access to resources Recommend Favorite

Serum visfatin in relation to insulin resistance and markers ofhyperandrogenism in lean and obese women with polycystic ovary syndrome

By Kowalska Irina   Straczkowski Marek   Nikolajuk Agnieszka   Adamska Agnieszka   Karczewska-Kupczewska Monika   Otziomek Elzbieta   Wolczynski Slawomir   Gorska Maria  

Human Reproduction, Vol. 22, Iss. 7, 2007-07 ,pp. : 1824-1829

Oxford University Press

Access to resources Recommend Favorite

A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight/obese women with polycystic ovary syndrome

By Mohsen Iman Abdel  

Gynecological Endocrinology, Vol. 28, Iss. 4, 2012-04 ,pp. : 269-272

Informa Healthcare

Access to resources Recommend Favorite